SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: jm2i123 who wrote (12271)8/2/2013 4:56:53 PM
From: NTTG1 Recommendation

Recommended By
Pogeu Mahone

  Read Replies (1) | Respond to of 13111
 
The study began recruiting subjects in Jan of this year and has been the topic of conversation several times since then. Only 15 subjects are participating, so not really sure what will be learned beyond a simple triage of possible markers for use in the PIII trial.